-
In September 2023, Endovastec received registration approval from the Thailand Food and Drug Administration for three key products: the Castor Branched Aortic Stent-Graft and Delivery System, the Minos Abdominal Aortic Stent-Graft and Delivery System, and the Hercules Thoracic Stent Graft System with Low Profile Delivery System. These devices are designed for endovascular treatment of thoracic and abdominal aortic diseases, enhancing options for minimally invasive interventions and expanding the company’s presence in the Southeast Asian market.
- In August 2022, W. L. Gore & Associates, Inc. announced the acquisition of InnAVasc Medical, a medical technology company focused on improving care for patients with end-stage renal disease who depend on graft circuits for dialysis. This acquisition strengthens Gore’s portfolio in vascular access solutions, supporting innovation and better patient outcomes in the dialysis segment, while expanding its influence in the medical device market.
